rb, let me add a bit to Chad's remarks, I'm a bit less skeptical regarding your "length" than he! If you really thought that about this stock, then you need more experience in the biotech area (and you're getting that right here right now with MNKD). Not to say what you thought could not happen; man, stuff happens all the time that surprises the heck out of me, but what you were thinking was certainly not likely to happen. You need to focus on market cap and not share price. A good partnership deal, and we're likely in double digits - $10 and maybe as high as $15. I don't think Al will sell the company at this point for any less than $20 given what must be his euphoria over the results, so that's not likely to happen soon.